Association of serum cortisol levels with parameters of metabolic syndrome in men and women Abstract Purpose: Central fat distribution is signi cantly associated with an increased cortisol levels. We hypothesized that men with metabolic syndrome have a higher serum cortisol levels compared to women. e purpose of this study was to compare serum cortisol levels, and its correlation with serum leptin levels, between men and women with and without metabolic syndrome.
Metabolic syndrome is a cluster of metabolic risk factors associated with cardiovascular disease and type 2 diabetes [1] . e major components of metabolic syndrome include excess abdominal fat, dyslipidemia, hypertension, hyperglycemia and increased in ammatory state [1] . For any given body mass index (BMI), mortality is higher if fat is distributed centrally, which is the major component of metabolic syndrome [2] .
Cross-sectional studies showed that morning cortisol levels are signi cantly correlated with the symptoms of metabolic syndrome, such as visceral obesity, high blood pressure and a poor lipid pro le [3] [4] [5] . Further studies suggest that metabolic syndrome is a less profound form of Cushing's syndrome, which is characterized by a rise in serum cortisol levels [4, [6] [7] [8] [9] .
is hypothesis is based on the simple observation that patients with Cushing's syndrome develop central obesity, which improves with the resolution of hypercortisolism [10, 11] .
It is known that men with metabolic syndrome are more frequently a ected with android obesity. Central fat distribution is signi cantly associated with increased cortisol levels [12, 13] , so it could be hypothesized that men with metabolic syndrome have a higher serum cortisol levels, due to increased abdominal obesity compared with women. On the other hand, adipose tissue is known as an endocrine organ, producing a number of cytokines including leptin [14, 15] . ere may be a gender di erence in the correlation of serum cortisol and leptin levels in men and women with metabolic syndrome. In this study, we aimed to compare serum cortisol levels, and its correlation with serum leptin levels, between men and women with and without metabolic syndrome.
Methods
A cross sectional analysis was performed with serum samples from 120 patients with metabolic syndrome from diabetes clinic of Vali-Asr hospital a liated with Tehran University of Medical Science, plus 165 healthy controls. Metabolic syndrome was de ned according to the criteria of National Cholesterol Education Program, Adult Treatment Panel III [16] . Under the ATPIII criteria, metabolic syndrome was de ned as the presence of three or more of the following risk factors: abdominal obesity (waist circumference ≥102 cm [men] or ≥88 cm [women]), triglyceride ≥150 mg/dL, HDL-cholesterol <40 mg/dL (men) or <50 mg/dL (women), blood pressure ≥130/ 85 mmHg and fasting plasma glucose ≥100 mg/dL (or diabetes). Exclusion criteria were pregnancy, acute or chronic renal failure, congestive heart failure, thyroid disorders, acute infections, stroke, use of glucocorticoid drugs and hospital admission within the past six months. Demographic and anthropometric data, including age, sex, height, weight in light clothing and blood pressure in sitting position, were recorded. Blood pressure was measured twice within 5 minutes and the values were averaged. BMI (kg/m 2 ) was calculated according to the uetelet formula. e biochemical tests, fasting blood sugar (FBS), lipid pro le, urine creatinine, serum insulin, cortisol and leptin levels were measured in all participants. All participants gave written informed consent before participation.
e research was carried out according to the Principles of the Declaration of Helsinki. e local ethics review committee of Tehran University of Medical Science approved the study protocol.
Blood samples were collected a er 12 hours of fasting at 8 am and serum creatinine, FBS, total cholesterol, triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), cortisol and insulin levels were measured. Glucose measurements (intra-assay coe cient of variants [CV] 2.1%, inter-assay CV 2.6%) were carried out using the glucose oxidase method. Cholesterol, HDL-C, LDL-C and TG were determined using direct enzymatic methods (Parsazmun, Karaj, Iran). Insulin was measured by radioimmunoassay, using an antibody with no cross reaction against proinsulin and C-peptide (Immunotech, Prague, Czech Republic).
e intra-and inter-assay coe cients of variation were lower than 4.3 and 3.4, respectively. Serum leptin concentration was determined by an enzyme-linked immunosorbent assay (DRG Instruments GmbH, Marburg, Germany) with an intra-assay coe cient of variation of 5.9-6.9% and an inter-assay coecient of variation of 8.6-11.5%. Serum cortisol concentration was measured by radioimmunoassay, using an antibody (Immunotech, Prague, Czech Republic) with an intra-assay coecient of variation of 3.5-5.1% and an inter-assay coe cient of variation of 5.4-9.2%. e homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as fasting insulin (mU/l) × fasting plasma glucose (mg/dl)/405, as described by Matthews et al. [17] . e statistical package SPSS 16 for Windows (Chicago, Illinois, USA) was used for analysis. uantitative variables are presented as mean±standard deviation (SD). For comparison of serum cortisol levels, lipid pro le and other variables among the patients with and without metabolic syndrome, and also men and women in each group, independent sample t-test andlinear models were employed to compare serum cortisol levels between men and women with metabolic syndrome a er multiple adjustments for age, waist circumference and BMI. e later analysis was repeated a er multiple adjustments for waistto-hip ratio. Signi cance was set at P <0.05.
Results
Characteristics of the participants are summarized in Table 1 . Serum cortisol levels did not di er between patients with and without metabolic syndrome. ere was a signi cant di erence between patients with and without metabolic syndrome in other studied variables.
To study the role of gender on serum cortisol and leptin levels, the participants in each group were strati ed into male and female for further analysis (Table 2) . Serum cortisol levels were signi cantly higher in men with metabolic syndrome, whereas serum leptin levels were signi cantly higher in women with metabolic syndrome (Table 2 ). A higher serum cortisol level in men with metabolic syndrome was signi cant a er multiple adjustments for age, BMI and waist circumference (17.74±5.1 vs 14.07±4.3; p<0.05) using general linear model; however, di erences were no long signi cant when waist-tohip ratio was included as one of the adjustment factors (16.7±1.2 vs 14.9±0.5; p<0.2).
Men and women without metabolic syndrome did not di er signi cantly in serum cortisol levels when there was a signi cant di erence in waist circumference, hip circumference, waist-to-hip ratio, lipid pro le, systolic and diastolic blood pressure, serum insulin and leptin levels. Table 3 presents the correlation of serum cortisol levels with other studied variables. Serum cortisol levels was signi cantly correlated with serum leptin (r=0.33, p<0.05), cholesterol (r=0.35, p<0.05), TG (r=0.25, p<0.05), waist circumference (r=0.41, p<0.01) and waist-to-hip ratio (r=0.32, p<0.01) in women with metabolic syndrome, a er controlling for age and BMI. ere was no signi cant correlation between serum cortisol level and any of the studied variables in men with metabolic syndrome (Table 3).
Discussion
Our ndings clearly demonstrate that men with metabolic syndrome have a higher serum cortisol levels compared with women, although there was no such sexual dimorphism in those without metabolic syndrome. e higher serum cortisol levels in men with metabolic syndrome were signi cant a er multiple adjustments for age, BMI and waist circumference; however, di erences were no long signi cant when waist-tohip ratio was included as one of the adjusting variables. Furthermore, serum cortisol levels were shown to be signi cantly correlated with waist circumference, waist-to-hip ratio, TG, total cholesterol and leptin levels in women with metabolic syndrome, a er multiple adjustments for age and BMI. e nding of a higher serum cortisol levels in men with metabolic syndrome is in general agreement with previous studies [18, 19] . Lamb et al. rst reported a higher urine free cortisol excretion rate in 15 men compared with 18 women, using radioimmunoassay [19] . ey studied healthy individuals and showed that this e ect was not correlated with the measurement techniques [19] . Fraser et al. suggested that serum cortisol levels are signi cantly higher in men with cardiovascular risk factors [20] . Using steady-state infusion of a tracer amount of stable isotope over 24 hour in 24 men and 30 women, Purnell et al. showed that an increased cortisol production rate is selectively correlated with visceral fat, not abdominal fat [21] . Furthermore, they showed that men have a signi cantly higher cortisol production rate, higher 24 h plasma free cortisol levels and a lower 24-h cortisol binding globulin (CBG) than women [21] .
Consistent with the data obtained from the national surveillance of waist circumference [22] , all studied women had a higher waist circumference compared with that seen in men with metabolic syndrome. On the other hand, men with metabolic syndrome had a higher waist-to-hip ratio, although this was not the case in patients without metabolic syndrome. Interestingly, the observed increase in serum cortisol levels seen in men with metabolic syndrome was no longer signi cant when waist-to-hip ratio was included in the analysis. Serum cortisol levels were also shown to be signi cantly correlated with serum leptin, cholesterol, TG, waist circumference and waist-to-hip ratio in women with metabolic syndrome a er multiple adjustments for age and BMI, whereas there was no signi cant correlation between serum cortisol levels and any of the studied variables in men with metabolic syndrome. Waistto-hip ratio is used as a measurement of obesity, which in turn is a possible indicator of other more serious health conditions. Waist-to-hip ratio has been found to be a more e cient predictor of mortality in older people than waist circumference or (BMI) [23] . A possible explanation for this observation would be that an increased serum cortisol level in men with metabolic syndrome may be associated with waist-to-hip ratio, however the direct correlation may be vanished due to the confounding e ect of unknown variables.
But why are serum cortisol levels correlated with risk factors of metabolic syndrome only in women with metabolic syndrome, despite relatively "normal" values and a lower serum cortisol levels than men? Previous studies suggested that increased serum cortisol level in men is mainly mediated through 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) activity [24, 25] . 11b-HSD1is a bidirectional enzyme, located in the abdominal fat mass and omental subcutaneous tissue, and mediates the conversion of cortisone to cortisol [26, 27] thermore there are gender di erences in 11b-HSD1 activity, which is greater in men [20] , and 5a-reductase activity, which is greater in women [28] . is di erence in enzyme activity may result in an increase in serum cortisol levels in men and would alter its degree of correlation with parameters associated with metabolic syndrome. As this would not happen in women with metabolic syndrome, the correlation is observed only in women.
Studies have demonstrated a direct relationship between stress-related psychopathologic symptoms and serum leptin levels [29] . Recently, it has been suggested that leptin can attenuate several parameters of cortisol secretion in female rhesus monkeys and thus play a role in the response of adrenal gland to socio-enviormental stimuli [30] . Serum leptin and cortisol levels predicts acute in ammatory reactions [31] . Furthermore, inhibiting serum cortisol would inhibit the rise in serum leptin levels [32] . Leptin is known to increase a er glucocorticoid administration and in Cushing's syndrome [33, 34] . Leptin is a cytokine and is found at signi cantly higher levels in women with metabolic syndrome [35] , so it could be hypothesized that it has more in uence on HPA axis in women. Consistent with this hypothesis, this study found a signi cant positive correlation between serum cortisol and leptin levels in women with metabolic syndrome. It has been repeatedly shown that women with metabolic syndrome have a higher risk of progression to cardiovascular disorders than men [36 37 ]. is may be another explanation for the observed association between serum leptin and cortisol levels in women.
In conclusion, increased serum cortisol levels were seen in men with metabolic syndrome.
e principal limitation of the present study is its cross-sectional nature, which precludes the determination of the direction of causality. Furthermore, CBG and ACTH were not measured, so simultaneously enhanced pituitary signaling could not be veri ed. On the other hand, we took advantage of a relatively large sample size and a close similarity between the groups for most of the potentially confounding clinical and laboratory variables. 
